ES8306321A1 - Un procedimiento para la produccion de un preparado en crema antiinflamatorio. - Google Patents

Un procedimiento para la produccion de un preparado en crema antiinflamatorio.

Info

Publication number
ES8306321A1
ES8306321A1 ES511402A ES511402A ES8306321A1 ES 8306321 A1 ES8306321 A1 ES 8306321A1 ES 511402 A ES511402 A ES 511402A ES 511402 A ES511402 A ES 511402A ES 8306321 A1 ES8306321 A1 ES 8306321A1
Authority
ES
Spain
Prior art keywords
added
water
cream preparation
preparation
carboxivinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511402A
Other languages
English (en)
Spanish (es)
Other versions
ES511402A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of ES511402A0 publication Critical patent/ES511402A0/es
Publication of ES8306321A1 publication Critical patent/ES8306321A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES511402A 1981-04-14 1982-04-13 Un procedimiento para la produccion de un preparado en crema antiinflamatorio. Expired ES8306321A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56056494A JPS57171912A (en) 1981-04-14 1981-04-14 Cream

Publications (2)

Publication Number Publication Date
ES511402A0 ES511402A0 (es) 1983-05-16
ES8306321A1 true ES8306321A1 (es) 1983-05-16

Family

ID=13028643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511402A Expired ES8306321A1 (es) 1981-04-14 1982-04-13 Un procedimiento para la produccion de un preparado en crema antiinflamatorio.

Country Status (5)

Country Link
US (1) US4514386A (enExample)
EP (1) EP0063870A3 (enExample)
JP (1) JPS57171912A (enExample)
CA (1) CA1194795A (enExample)
ES (1) ES8306321A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
DE3323832A1 (de) * 1983-07-01 1985-01-03 Troponwerke Gmbh & Co Kg Etofenamat-zubereitung
DE3323833A1 (de) * 1983-07-01 1985-01-03 Troponwerke Gmbh & Co Kg Etofenamat-zubereitung
US4731384A (en) * 1983-07-01 1988-03-15 Troponwerke Gmbh & Co, Kg Etofenamate formulation
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
EP0142159B1 (de) * 1983-11-17 1991-07-03 Opel, Helmut, Dr.med. Oberflächenanalgetikum und -antiphlogistikum
GB8416638D0 (en) * 1984-06-29 1984-08-01 Beecham Group Plc Topical treatment and composition
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
US5296166A (en) * 1987-04-10 1994-03-22 Jerry Leong Method of manufacturing emulsions
DE3724691C2 (de) * 1987-07-25 1999-03-18 Konrad Minninger Pharmazeutisches Mittel zur lokalen Therapie von schuppenden Hautkrankheiten
ATE91079T1 (de) * 1989-01-25 1993-07-15 Wolff Chem Pharm Gmbh Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5767153A (en) * 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
EP0995435B1 (en) * 1997-05-14 2007-04-25 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
RU2140258C1 (ru) * 1999-03-17 1999-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Гидрофильная фармацевтическая композиция, обладающая противовоспалительным действием
US6942771B1 (en) 1999-04-21 2005-09-13 Clinical Micro Sensors, Inc. Microfluidic systems in the electrochemical detection of target analytes
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
RU2610855C2 (ru) * 2015-03-23 2017-02-16 Общество с ограниченной ответственностью Реабилитационно-оздоровительный центр "Ариадна" Крем для миофасциального массажа
US11839669B2 (en) 2021-10-06 2023-12-12 Suncoast Products LLC Cosmetic emulsion bases (CEB)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2522178A1 (de) * 1975-05-17 1976-11-25 Bayer Ag Granulate und pulver zur herstellung von salben
GB1547164A (en) * 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
US4044140A (en) * 1975-11-28 1977-08-23 Schering Corporation Trityl picolinic acid derivatives and their use as anti-acne agents
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments

Also Published As

Publication number Publication date
ES511402A0 (es) 1983-05-16
CA1194795A (en) 1985-10-08
JPH0250882B2 (enExample) 1990-11-05
US4514386A (en) 1985-04-30
EP0063870A3 (en) 1983-06-22
EP0063870A2 (en) 1982-11-03
JPS57171912A (en) 1982-10-22

Similar Documents

Publication Publication Date Title
ES8306321A1 (es) Un procedimiento para la produccion de un preparado en crema antiinflamatorio.
US4309414A (en) Antiinflammatory analgesic gelled ointment
BE901359A (fr) Composition pharmaceutique a absorption reglee.
ES534598A0 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
NO863935D0 (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
DE3478396D1 (en) Controlled absorption pharmaceutical formulation
GB1298494A (en) Phenylethanolamine derivatives
IE791995L (en) Formulation
ES2008420A6 (es) Procedimiento de obtencion de un preparado seco adecuado para la fabricacion de una suspension acuosa de una sal de diclofenac
SE8501312D0 (sv) Etoposide oral dosage form
ES2155119T3 (es) Procedimiento para la preparacion de un producto medicamentoso.
ES2059450T3 (es) Nuevos derivados de cisteina que tienen actividad expectorante.
JPH0345043B2 (enExample)
BE905113A (fr) Nouveaux derives d'acides ceph-3-em-4-carboxylique, leur preparation et medicaments les contenant.
SE8204792D0 (sv) N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt
BE1002657A5 (fr) Preparation vitaminee contenant l'enzyme lysozyme utilisable pour l'elevage des animaux et procede pour sa production.
Mukherjee et al. THE EFFECT OF TETRACYCLINE ON SYNTHESIS OF FATTY ACID AND CHOLESTEROL IN THE LIVER OF CONTROL AND EXPERIMEN AL RATS
IE811209L (en) Indole acetic acid derivatives
ES2044148T3 (es) Disoluciones acuosas de doxorubicina.
Rainsford Aspirin, Prostaglandins and mucopolysaccharide/glycoprotein secretion
GB1133845A (en) Pharmaceutical compositions comprising dextran and cellulose ethers
ECSP910716A (es) Procedimiento para preparar un producto de celulosa oxidada, neutralizada y metodo de uso del mismo
FR2430424A1 (fr) Procede pour la preparation de sels d'acide (-)cis-1,2-epoxypropylphosphonique
ES8604885A2 (es) Mejoras en el objeto de la patente de invencion n 527.268 que se refiere a procedimiento de obtencion de nuevos derivados imidazolicos del acido 2-hidroxibenzoico
GB1392004A (en) Propoxyphene salts